<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960412</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00026976</org_study_id>
    <nct_id>NCT02960412</nct_id>
  </id_info>
  <brief_title>Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy</brief_title>
  <official_title>Randomized Controlled Trial Evaluating Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if administration of IV furosemide leads to expedited confirmation of
      ureteral patency when compared to placebo (IV saline) in routine cystoscopy performed after
      urogynecologic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cystoscopy is performed routinely after urogynecologic surgery to ensure there was no injury
      to the urinary tract (urethra, bladder, or ureters). In order to confirm that no damage
      occurred to the ureters, a jet of urine must be visualized from each ureteral opening.

      The time it takes to confirm this ureteral patency is variable and some sources suggest using
      furosemide to decrease the time it takes to see these jets. This study will evaluate what
      effect, if any, this medicine has on time to confirming ureteral patency.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">March 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to ureteral patency</measure>
    <time_frame>intra-operative</time_frame>
    <description>time to confirmation of ureteral patency in seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse effects from furosemide administration</measure>
    <time_frame>immediately post operative (1-3 days post operatively)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Cystoscopy</condition>
  <arm_group>
    <arm_group_label>furosemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>furosemide 10mg (1mL) IV push for one dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline 1mL IV push for one dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>furosemide</intervention_name>
    <description>10mg lasix given intraoperatively</description>
    <arm_group_label>furosemide</arm_group_label>
    <other_name>Lasix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Normal saline given intraoperatively as placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing any urogynecologic surgery

          -  No allergy or contraindication to receiving furosemide

          -  Normal Creatinine/glomerular filtration rate

        Exclusion Criteria:

          -  Unable to consent, including if non English speaking

          -  Allergy or contraindication to receiving furosemide

          -  Intraoperative injury to the lower urinary tract
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 29, 2019</submitted>
    <returned>May 23, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

